What conditions have the most trials recruiting in Arendal, Norway?

In Arendal, Norway, the conditions with the most recruiting trials are Anxiety (1), Anxiety Depression (1), Carcinoma, Non-Small-Cell Lung (1).

Clinical trials recruiting in Arendal, Norway

Recruiting trials

Conditions

Phase 2 1Phase 3 2Not applicable 3

Condition	Trials
Anxiety	1
Anxiety Depression	1
Carcinoma, Non-Small-Cell Lung	1
Cardiovascular Diseases	1
Colorectal Neoplasms	1
Colorectal cancer	1
Depression	1
Depression - Major Depressive Disorder	1
Depression Anxiety Disorder	1
Diabetes Mellitus, Type 2	1
Heart Failure	1
Hypertension	1
Lung cancer	1
Parkinson Disease (PD)	1
Parkinson s Disease	1

D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
NCT07312110 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
Group-based ACT for Psychological Distress of Young People
NCT07617467 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 25 Years · Sex: All (male and female)
Management of Patients With Heart Failure at Home After Hospital Discharge
NCT06576752 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance
NCT06983639 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 75 Years · Sex: All (male and female)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
NCT06890598 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)